315
Participants
Start Date
October 25, 2022
Primary Completion Date
April 9, 2027
Study Completion Date
April 8, 2028
PF-08046054
Given into the vein (IV; intravenously)
pembrolizumab
200 mg once every 3 weeks given into the vein (IV; intravenously)
RECRUITING
Institut Jules Bordet, Anderlecht
RECRUITING
Charite Comprehensive Cancer Center, Berlin
RECRUITING
Charite Universitatsmedizin Berlin, Berlin
RECRUITING
Apotheke-Zytostatika Studien Charite- Universitatsmedizin Berlin Campus Virchow Klinkum, Berlin
RECRUITING
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative lstituto Europeo di Oncologia, Milan
RECRUITING
NEXT Virginia, Fairfax
RECRUITING
START Madrid - CIOCC - Hospital Universitario HM Sanchinarro, Madrid
RECRUITING
Hôpital Saint André - CHU Bordeaux, Bordeaux
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
University of Alabama at Birmingham, IDS Pharmacy, Birmingham
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Centro Ricerche Cliniche di Verona s.r.l. c/o Policlinico G.B Rossi, Verona
RECRUITING
Azienda Ospedaliera Universitaria Integrata Verona - Policlinico G.B Rossi, Verona
RECRUITING
UOC Oncologia - IRCCS Azienda Ospedaliero Universitaria Bologna, Bologna
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
Karmanos Cancer Institute, Farmington Hills
RECRUITING
University of Iowa Hospitals & Clinics, Iowa City
RECRUITING
lnstitut Curie Pharmacy, Paris
NOT_YET_RECRUITING
UT Southwestern - Simmons Cancer Center - Richardson/Plano, Richardson
NOT_YET_RECRUITING
University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
NOT_YET_RECRUITING
UT Southwestern Medical Center - Redbird, Dallas
RECRUITING
Institut Curie, Paris
NOT_YET_RECRUITING
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
NOT_YET_RECRUITING
University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital, Dallas
NOT_YET_RECRUITING
University Of Texas Southwestern Medical Center, Dallas
NOT_YET_RECRUITING
UT Southwestern - Simmons Cancer Center - Fort Worth, Fort Worth
RECRUITING
The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
South Texas Accelerated Research Therapeutics, LLC, San Antonio
RECRUITING
START Mountain Region, West Valley City
RECRUITING
Clinique Ambroise Pare, Neuilly-sur-Seine
RECRUITING
Gustave Roussy Institute - Service pharmacie, Villejuif
RECRUITING
University of California Davis Comprehensive Cancer Center, Sacramento
RECRUITING
University of California, Davis Medical Center, Sacramento
NOT_YET_RECRUITING
Beijing Friendship Hospital, Capital Medical University, Beijing
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Shanghai East Hospital, Shanghai
NOT_YET_RECRUITING
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
RECRUITING
University Health Network, Princess Margaret Hospital, Toronto
RECRUITING
McGill University Health Centre, Montreal
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Shizuoka Cancer Center, Nagaizumi-cho
RECRUITING
The Netherlands Cancer Institute, Amsterdam
RECRUITING
CETIR Viladomat, Barcelona
RECRUITING
Hospital Duran I Reynals-Institut Català d'Oncologia L'Hospitalet (ICO L'Hospitalet), Barcelona
RECRUITING
Hospital Quiron Salud Barcelona, Barcelona
RECRUITING
NEXT Oncology Barcelona - IOB - Hospital Quironsalud Barcelona, Barcelona
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
RECRUITING
Diagnostic Centre, London
RECRUITING
The Harley Street Clinic (THSC), London
RECRUITING
Sarah Cannon Research Institute, London
RECRUITING
Pharmacy: Royal Marsden Hospital, Sutton
RECRUITING
Royal Marsden Hospital, Sutton
RECRUITING
The Royal Marsden NHS Foundation Trust, London
RECRUITING
Radiology, London
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY